Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
13 September 2024 - 6:05AM
Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics
contract development and manufacturing organization (CDMO) working
to improve patient lives by providing high quality development and
manufacturing services to biotechnology and pharmaceutical
companies, today announced that the company will participate in the
upcoming Craig-Hallum Bioprocessing Conference. Nick Green,
president and chief executive officer, and Pramthesh Patel, Ph.D.,
vice president of process development, will be the featured
speakers in a fireside chat at the conference, which will take
place virtually on September 19, 2024.
Details of the company’s participation are as follows:
- Craig-Hallum Bioprocessing
ConferenceDetails: Mr. Green and Dr. Patel will
participate in a fireside chatConference Date: September 19,
2024Fireside Chat Timing: 2:45 p.m. Eastern on Thursday, September
19, 2024Format: Virtual
Following the fireside chat, a webcast replay
will be available via a link on Avid’s investor website at:
http://ir.avidbio.com/investor-events.
About Avid Bioservices,
Inc.
Avid Bioservices (NASDAQ: CDMO) is a
dedicated contract development and manufacturing organization
(CDMO) focused on development and CGMP manufacturing of biologics.
The company provides a comprehensive range of process development,
CGMP clinical and commercial manufacturing services for the
biotechnology and biopharmaceutical industries. With more than 30
years of experience producing biologics, Avid's services include
CGMP clinical and commercial drug substance manufacturing, bulk
packaging, release and stability testing and regulatory submissions
support. For early-stage programs the company provides a variety of
process development activities, including cell line development,
upstream and downstream development and optimization, analytical
methods development, testing and characterization. The scope
of our services ranges from standalone process development projects
to full development and manufacturing programs through
commercialization. www.avidbio.com
Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMOP)
Historical Stock Chart
From Nov 2024 to Dec 2024
Avid Bioservices (NASDAQ:CDMOP)
Historical Stock Chart
From Dec 2023 to Dec 2024